| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.
Most recently, BioNTech reported earnings per share at $2.2, whereas in Q4 earnings per share sat at $9.45. Leafly Holdings has reported Q1 earnings per share at $-0.14, which has increased by 17.65% compared to Q4, which was -0.17. Innoviva saw an increase in earnings per share from -0.98 in Q4 to $0.42 now. Pfizer's earnings per share for Q1 sits at $1.23, whereas in Q4, they were at 1.14. The company's most recent dividend yield sits at 4.17%, which has increased by 1.0% from 3.17% last quarter.
Most recently, Organon reported earnings per share at $1.11, whereas in Q4 earnings per share sat at $0.81. The company's most recent dividend yield sits at 4.62%, which has increased by 0.79% from 3.83% last quarter.
These 5 value stocks were selected by Benzinga Insights based on quantified analysis. While this methodical judgment process is not meant to make final decisions, our technology can give investors additional perception into the sector.
